LISATA THERAPEUTICS, INC. Fair Value, Net Asset (Liability)
LISATA THERAPEUTICS, INC. (LSTA) had Fair Value, Net Asset (Liability) of $0 as of 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:FairValueNetAssetLiability · last filed 2016-03-15
- 2015-12-31: Fair Value, Net Asset (Liability) $0.00.
- 2014-12-31: Fair Value, Net Asset (Liability) $18.26M.
- 2013-12-31: Fair Value, Net Asset (Liability) $9.47M.
| Period end | Fair Value, Net Asset (Liability) |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-15 |
| 2014-12-31 | $18.26M 10-K · filed 2016-03-15 |
| 2013-12-31 | $9.47M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |